Thyroid-associated ophthalmopathy is an organ specific autoimmune disease,which ranks top among the orbital diseases with the highest incidences,but its pathogenesis is still unclear and the treatment is yet to be standardized.We need to monitor patients' sight more intensively,attach more importance to a regularized application of the glucocorticoid,and make more use of surgery to maximally protect and save patients' sight,improve their countenance and upgrade their quality of life.
范先群. 积极开展甲状腺相关眼病手术,重视糖皮质激素的规范化治疗[J]. 中华眼视光学与视觉科学杂志, 2012, 14(5): 257-259.
FAN Xian-qun. On actively promoting surgery and standardized glucocorticoid treatment for thyroid-associated ophthalmopathy. Chinese Journal of Optometry Ophthalmology and Visual Science, 2012, 14(5): 257-259. DOI: 10.3760/cma.j.issn.1674-845X.2012.05.001